Problems - Example 7
A case with a high profile involving research integrity questions
Researchers to get a bill of rights from P&G
Times Higher February 24th 2006
http://www.thes.co.uk/search/story.aspx?story_id=2028150
Half hour long BBC Radio Broadcast
Vivienne Parry investigates if Proctor and Gamble attempted to boost the
sales of one of its drugs by hindering
independent scientific research (23
Feb 2006).
http://www.bbc.co.uk/radio4/youandyours/items/01/2006_08_thu.shtml
Experts cast doubt over scientists' claims for Actonel
Times Higher Published: 24 February 2006
http://www.thes.co.uk/search/story.aspx?story_id=2028151
Efficacy of Osteoporosis Medicine Challenged
by Richard Harris (NPR Radio, USA)
A British scientist has been in the United States this week alleging that a
big drugmaker has been playing fast and loose
with data to make its medicine
look good. The drug in question is Actonel,
used for treating osteoporosis
and a big earner for Procter & Gamble.
Audio at:
http://www.npr.org/templates/story/story.php?storyId=5234621
Scientist Presses Claim P&G Misrepresented Actonel Data
By SARAH ELLISON, February 23, 2006, The Wall Street Journal
http://online.wsj.com/article/SB114066368502780947.html
Data row sparks research debate
Times Higher Education Supplement 25 Nov 05
http://www.thes.co.uk/search/story.aspx?story_id=2026283
When access to data is a real bone of contention
Times Higher Education Supplement 25 Nov 05
http://www.thes.co.uk/search/story.aspx?story_id=2026307
Doctor in drug research row quits NHS post
Jo Revill, Sunday January 15, 2006, The Observer
http://observer.guardian.co.uk/uk_news/story/0,,1686705,00.html